Polosa R, Pagano C, Low J L, Church M K, Crimi N
Istituto di Malattie dell'Apparato Respiratorio, Università degli Studi di Catania.
Ann Ital Med Int. 1999 Apr-Jun;14(2):86-93.
Nasal provocation with adenosine 5'-monophosphate elicits nasal symptoms in subjects with rhinitis. Histamine released from airway mast cells may play a role in adenosine-induced nasal responses. To investigate the possible role of histamine in mediating adenosine-induced nasal responses, we measured its release in the fluid obtained by nasal lavage after adenosine 5'-monophosphate, guanosine 5'-monophosphate, and placebo instillations. Nasal lavages were performed before and 3, 5, 10, 15, 30 and 45 min after challenge with adenosine 5'-monophosphate, guanosine 5'-monophosphate, and normal saline in 11 patients with rhinitis and 7 normal subjects in a double-blind randomized placebo-controlled cross-over study to evaluate symptoms and to monitor changes in histamine levels. No symptoms or significant increases in histamine were observed after guanosine 5'-monophosphate and placebo challenge. Symptom scores increased in response to adenosine 5'-monophosphate challenge in the rhinitic subjects but not in the normal controls. Nasal provocation with adenosine elicited a significant release of histamine in the nasal lavage fluids with an immediate peak response: its median (range) concentration increased from the baseline value of 1.33 (0.16-14.54) ng/mL to 2.68 (0.31-61.11) ng/mL at 3 min. However, increased histamine levels were not associated with nasal symptom scores. When compared to non-atopic subjects, significantly higher levels of histamine were seen in the nasal lavage fluids of the atopic subjects following adenosine challenge. In the atopic subjects, the median (range) histamine concentration increased from the baseline value of 1.54 (0.16-14.54) ng/mL to that of 4.21 (0.70-61.11) ng/mL at 3 min, whereas no increment was seen in the non-atopic subjects, their histamine concentration being 0.81 (0.29-5.56) ng/mL and 0.74 (0.31-14.25) ng/mL at baseline and 3 min after adenosine challenge respectively. These findings indicate that adenosine elicits nasal responses in patients with rhinitis but not in normal controls. Moreover, adenosine elicits an immediate rise in histamine levels in the nasal lavage fluid, with the highest rise in atopic compared to non-atopic volunteers, suggesting that the nasal responses to adenosine may be an index of mast cell priming.
用5'-单磷酸腺苷进行鼻腔激发试验可使鼻炎患者出现鼻腔症状。气道肥大细胞释放的组胺可能在腺苷诱导的鼻腔反应中起作用。为了研究组胺在介导腺苷诱导的鼻腔反应中的可能作用,我们测量了在给予5'-单磷酸腺苷、5'-单磷酸鸟苷和安慰剂滴鼻后通过鼻腔灌洗获得的液体中组胺的释放量。在一项双盲随机安慰剂对照交叉研究中,对11例鼻炎患者和7名正常受试者在给予5'-单磷酸腺苷、5'-单磷酸鸟苷和生理盐水激发前及激发后3、5、10、15、30和45分钟进行鼻腔灌洗,以评估症状并监测组胺水平的变化。给予5'-单磷酸鸟苷和安慰剂激发后未观察到症状或组胺显著增加。鼻炎患者对5'-单磷酸腺苷激发的症状评分增加,而正常对照组则无增加。用腺苷进行鼻腔激发试验可使鼻腔灌洗液中组胺显著释放,出现立即峰值反应:其浓度中位数(范围)从基线值1.33(0.16 - 14.54)ng/mL在3分钟时增加到2.68(0.31 - 61.11)ng/mL。然而,组胺水平升高与鼻腔症状评分无关。与非特应性受试者相比,特应性受试者在腺苷激发后鼻腔灌洗液中的组胺水平显著更高。在特应性受试者中,组胺浓度中位数(范围)从基线值1.54(0.16 - 14.54)ng/mL在3分钟时增加到4.21(0.70 - 61.11)ng/mL,而非特应性受试者未见增加,其组胺浓度在基线时为0.81(0.29 - 5.56)ng/mL,腺苷激发后3分钟时为0.74(0.31 - 14.25)ng/mL。这些发现表明,腺苷可使鼻炎患者出现鼻腔反应,但正常对照组不会。此外,腺苷可使鼻腔灌洗液中组胺水平立即升高,与非特应性志愿者相比,特应性患者升高幅度最大,提示对腺苷的鼻腔反应可能是肥大细胞致敏的一个指标。